我国医用聚氯乙烯增塑剂的发展现状  

Current Progress in Plasticizers for Medical Poly (vinyl chloride)s in China

作　　者：李翠翠[1] 何成生[1] 樊翠蓉[1] 钟银屏[1] 

机构地区：[1]四川大学高分子科学与工程学院,成都610065

出　　处：《材料导报》2010年第5期141-144,共4页Materials Reports

摘　　要：我国医用聚氯乙烯(PVC)以可致癌的邻苯二甲酸二辛酯(DOP)为主增塑剂,这严重影响了国内人民的健康和医用PVC行业的发展。通过对国内外各新型环保增塑剂的比较可知:无毒环保的乙酰柠檬酸三丁酯(ATBC)适合作为我国医用PVC制品的主增塑剂。这为改善医用PVC制品使用者的健康状态,加快医用环保PVC行业的发展提出了可行性。Dioctyl phthalate（DOP） currently is the main plasticizer for medical poly（vinyl chloride）s（PVCs） in China. Due to its potentially cancer-inducing and toxic risks, DOP has caused problems to patientsr health, preventing the development of national industry of medical PVCs. The development of environment-friendly plasticizers in the world is focused in this article. It can be seen that acetyl tributyl citrate （ATBC） may be one of the best plasticizer for medical PVCs. Such plasticizer can improve safty and quality of PVC products, thereby accerlerating the development of medical PVC industry in China.

关 键 词：环氧大豆油 柠檬酸酯 二甘醇二苯甲酸酯 己二酸酯 高分子增塑剂 Eastman168增塑剂 

分 类 号：TQ325.3[化学工程—合成树脂塑料工业] TQ414